Overall, the biomarkers notably constitute genes that participate in breast cancer related pathways (e.g. marker genes involved in estrogen receptor pathway) and genes that were previously implicated in other cancer types (e.g. GSTP1, FLT1, see Table 8). The gene discussed is FLT1; the disease is breast carcinoma.